Vineet Laboratories Shareholders Approve Independent Director Appointment in EGM

2 min read     Updated on 07 Feb 2026, 11:01 PM
scanx
Reviewed by
Ashish TScanX News Team
Overview

Vineet Laboratories Limited held its Extra-Ordinary General Meeting on February 07, 2026, where shareholders approved the appointment of Ms. Jasmin Kunal Tailor as Independent Director with 99.99% votes in favor. The meeting was conducted via video conferencing with participation from 51 shareholders, and the e-voting process was managed by CDSL with scrutinizer oversight by Mr. Jineshwar Kumar Sankhala from P S Rao & Associates.

32031063

*this image is generated using AI for illustrative purposes only.

Vineet Laboratories Limited successfully concluded its Extra-Ordinary General Meeting on February 07, 2026, with shareholders providing overwhelming support for a key board appointment. The meeting, conducted through video conferencing from 11:00 AM to 11:45 AM, focused on a single special resolution regarding the appointment of an Independent Director.

Meeting Overview and Participation

The EGM was held in compliance with regulatory requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. With a record date of January 30, 2026, the company had 10106 total shareholders eligible to participate.

Meeting Details: Information
Date: February 07, 2026
Duration: 11:00 AM to 11:45 AM
Mode: Video Conferencing
Record Date: January 30, 2026
Total Shareholders: 10106

The meeting witnessed participation from 51 shareholders through video conferencing, including 12 from the promoter and promoter group category and 39 from the public category. No shareholders attended the meeting in person or through proxy.

Resolution Details and Voting Results

The sole agenda item was a special resolution for the appointment of Ms. Jasmin Kunal Tailor (DIN: 10794164) as an Independent Director of the company. The promoter and promoter group were not interested in this particular resolution, ensuring independent decision-making by shareholders.

Voting Category: Shares Held Votes Polled Votes in Favor Votes Against Approval Rate
Promoter Group: 1149097 1147322 1147322 0 100%
Public Non-Institutions: 8069911 71972 71894 78 99.89%
Public Institutions: 0 0 0 0 N/A
Total: 9219008 1219294 1219216 78 99.99%

E-Voting Process and Scrutinizer Report

The voting process was conducted electronically through Central Depository Services Limited (CDSL) platform. Remote e-voting was available from February 04, 2026, at 09:00 AM to February 06, 2026, at 05:00 PM, followed by e-voting facility during the EGM for eligible shareholders.

Mr. Jineshwar Kumar Sankhala from P S Rao & Associates served as the scrutinizer for the meeting. He was appointed by the Board of Directors on January 07, 2026, and submitted his report on February 07, 2026, confirming the validity and transparency of the voting process.

Resolution Outcome

The special resolution was passed with overwhelming support, receiving 1219216 votes in favor representing 99.99% of total valid votes cast. Only 78 votes were cast against the resolution, representing 0.01% of the total. The strong approval rate demonstrates shareholder confidence in the proposed appointment.

Vote Summary: Count Percentage
Total Valid Votes: 1219294 100%
Votes in Favor: 1219216 99.99%
Votes Against: 78 0.01%
Invalid Votes: 0 0%

The voting results and scrutinizer's report have been made available on the company's website at www.vineetlabs.co.in and on CDSL's e-voting portal at www.evotingindia.com , ensuring transparency and regulatory compliance.

Historical Stock Returns for Vineet Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-4.39%-9.09%-14.98%-13.29%-29.91%-23.01%

Vineet Laboratories Completes Rights Issue Allotment of 99,87,258 Equity Shares

1 min read     Updated on 02 Feb 2026, 06:20 PM
scanx
Reviewed by
Riya DScanX News Team
Overview

Vineet Laboratories Limited completed the allotment of 99,87,258 equity shares through rights issue on February 02, 2026, at Rs.30 per share including Rs.20 premium. The successful allotment increased the company's paid-up capital from Rs.9,21,90,080 to Rs.19,20,62,660, more than doubling the equity base. The process was conducted in compliance with SEBI regulations and approved by BSE Limited as the designated stock exchange.

31582213

*this image is generated using AI for illustrative purposes only.

Vineet Laboratories Limited has successfully completed the allotment of equity shares through its rights issue, marking a significant milestone in the company's capital expansion plans. The Rights Issue Committee of the Board of Directors approved the allotment on February 02, 2026, in compliance with regulatory requirements.

Rights Issue Details

The company allotted 99,87,258 equity shares with a face value of Rs.10 each through the rights issue mechanism. The shares were priced at Rs.30 per equity share, which includes a premium of Rs.20 per share above the face value.

Parameter: Details
Number of Shares Allotted: 99,87,258
Face Value per Share: Rs.10
Issue Price per Share: Rs.30
Premium per Share: Rs.20
Letter of Offer Date: December 17, 2025

Capital Structure Transformation

The rights issue has resulted in a substantial increase in the company's paid-up share capital. The allotment more than doubled the company's equity base, reflecting strong investor participation in the offering.

Particulars: No. of Equity Shares Total Paid-up Share Capital (Rs.)
Pre-Rights Issue: 92,19,008 9,21,90,080
Post-Rights Issue: 1,92,06,266 19,20,62,660

Regulatory Compliance and Process

The allotment was conducted in accordance with the terms outlined in the Letter of Offer dated December 17, 2025. The basis of allotment was finalized in consultation with Bigshare Services Private Limited, which served as the Registrar to the Issue. BSE Limited acted as the designated stock exchange for the rights issue, providing regulatory oversight and approval for the allotment process.

The company has fulfilled its disclosure obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Rights Issue Committee meeting commenced at 5:35 PM and concluded at 5:45 PM on February 02, 2026, demonstrating efficient decision-making processes.

Corporate Structure

Vineet Laboratories Limited, incorporated under CIN L24304TG2016PLC112888, operates from its registered office in Hyderabad. The company maintains its listing on both BSE Limited (Scrip Code: 543298) and National Stock Exchange of India Limited (Scrip Code: VINEETLAB), ensuring broad market accessibility for investors.

Historical Stock Returns for Vineet Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-4.39%-9.09%-14.98%-13.29%-29.91%-23.01%

More News on Vineet Laboratories

1 Year Returns:-29.91%